Treatment regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Organisms4

Helicobacter pylori HIV-1 Mycobacterium tuberculosis HIV

Diseases36

HIV Infections Recurrence Tuberculosis, Multidrug-Resistant Tuberculosis Helicobacter Infections Neoplasms Tuberculosis, Pulmonary Lung Neoplasms Lymphoma, Non-Hodgkin Neutropenia Disease Progression Breast Neoplasms Disease Models, Animal Nausea Brain Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Precursor Cell Lymphoblastic Leukemia-Lymphoma Extensively Drug-Resistant Tuberculosis Hodgkin Disease Anaplasia Mycobacterium Infections, Nontuberculous Acute Disease Periarthritis Multiple Myeloma Malaria, Falciparum Gonorrhea Urethritis Drug-Related Side Effects and Adverse Reactions Colorectal Neoplasms Wilms Tumor Diabetes Mellitus, Type 2 Adenocarcinoma Duodenal Ulcer Chronic Disease Pelvic Inflammatory Disease

Chemicals and Drugs121

Antitubercular Agents Cyclophosphamide Anti-Bacterial Agents Drug Combinations Anti-HIV Agents Antineoplastic Agents Pyrazinamide Vincristine Rifampin Isoniazid Doxorubicin Fluorouracil Cisplatin Methotrexate Prednisone Metronidazole Amoxicillin Ethambutol Etoposide Bismuth Immunosuppressive Agents Clarithromycin Doxycycline Antibiotics, Antitubercular Antimalarials Diarylquinolines Deoxycytidine Cytarabine Paclitaxel Anti-Infective Agents Benzoxazines Artemisinins Ritonavir Antiviral Agents Antibodies, Monoclonal Anti-Ulcer Agents Reverse Transcriptase Inhibitors HIV Protease Inhibitors Antineoplastic Agents, Alkylating Ofloxacin Penicillin G Benzathine Vinblastine Leucovorin Penicillins Omeprazole Tinidazole Leprostatic Agents Azithromycin Carboplatin Ifosfamide Taxoids Antibodies, Monoclonal, Humanized Organoplatinum Compounds Organophosphonates Bleomycin Sesquiterpenes Hypoglycemic Agents Tetracycline Penicillin G Procaine Interferon-alpha Rifamycins Streptomycin Asparaginase Primaquine Lamivudine Stavudine Levofloxacin Nevirapine Anthelmintics Adrenal Cortex Hormones Dacarbazine Saquinavir Melphalan Antimetabolites, Antineoplastic Anti-Retroviral Agents Ranitidine Mefloquine Prednisolone Antineoplastic Agents, Phytogenic 2-Pyridinylmethylsulfinylbenzimidazoles Antibodies, Monoclonal, Murine-Derived Camptothecin Quinolines Pyrimethamine Recombinant Proteins Fluorenes Ciprofloxacin Glucocorticoids Antihypertensive Agents Antacids Fluoroquinolones Angiogenesis Inhibitors Zidovudine Amikacin Daunorubicin Dexamethasone Sulfadoxine Anti-Inflammatory Agents Antifungal Agents Probenecid Gentamicins Spectinomycin Pyrazines Ribavirin Hydrochlorothiazide Busulfan Amphotericin B Polyethylene Glycols Ethanolamines Thalidomide Cyclosporine Adenine Proton Pump Inhibitors Antiprotozoal Agents RNA, Viral Trimethoprim Lansoprazole Mitomycin Antirheumatic Agents Vancomycin Ceftriaxone

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Drug Therapy, Combination Treatment Outcome Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Administration, Oral Treatment Failure Retrospective Studies Prospective Studies Survival Analysis Clinical Trials as Topic Follow-Up Studies Double-Blind Method Disease-Free Survival Survival Rate Infusions, Intravenous Prognosis Remission Induction Drug Substitution Antiretroviral Therapy, Highly Active Randomized Controlled Trials as Topic Salvage Therapy Viral Load Neoplasm Staging Directly Observed Therapy Area Under Curve Microbial Sensitivity Tests Chemotherapy, Adjuvant Random Allocation Pilot Projects CD4 Lymphocyte Count Retreatment Injections, Intravenous Injections, Intramuscular Disease Models, Animal Risk Factors Clinical Trials, Phase II as Topic Administration, Topical Cohort Studies Drug Evaluation Radiotherapy Drug Monitoring Hematopoietic Stem Cell Transplantation Kaplan-Meier Estimate Severity of Illness Index Transplantation, Autologous Neoadjuvant Therapy Photochemotherapy Feasibility Studies Bone Marrow Transplantation Injections, Subcutaneous Transplantation Conditioning Xenograft Model Antitumor Assays Colony Count, Microbial Cross-Over Studies Radiotherapy, Adjuvant Radiotherapy Dosage Dose Fractionation Immunotherapy Transplantation, Homologous Ultraviolet Therapy Multivariate Analysis Clinical Trials, Phase III as Topic Clinical Protocols Maximum Tolerated Dose Drug Therapy Endpoint Determination

Psychiatry and Psychology3

Patient Compliance Medication Adherence Treatment Refusal

Phenomena and Processes18

Time Factors Dose-Response Relationship, Drug Viral Load Drug Resistance, Viral Area Under Curve CD4 Lymphocyte Count Drug Resistance, Bacterial Drug Interactions Drug Resistance, Multiple, Viral Drug Synergism Drug Resistance, Neoplasm Drug Resistance Drug Tolerance Pregnancy Drug Resistance, Microbial Genotype Maximum Tolerated Dose Half-Life

Anthropology, Education, Sociology and Social Phenomena2

Treatment Refusal Quality of Life

Technology, Industry, Agriculture1

Polyethylene Glycols

Humanities1

Quality of Life

Information Science1

Health Care32

Treatment Outcome Patient Compliance Treatment Failure Retrospective Studies Prospective Studies Survival Analysis Clinical Trials as Topic Follow-Up Studies Double-Blind Method Disease-Free Survival Survival Rate Drug Substitution Medication Adherence Randomized Controlled Trials as Topic Area Under Curve Random Allocation Pilot Projects Drug Costs Risk Factors Clinical Trials, Phase II as Topic Cohort Studies Practice Guidelines as Topic Cost-Benefit Analysis Kaplan-Meier Estimate Treatment Refusal Severity of Illness Index Feasibility Studies Cross-Over Studies Age Factors Multivariate Analysis Clinical Trials, Phase III as Topic Clinical Protocols

Geographicals1

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Drug Therapy, Combination Treatment Outcome Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Antitubercular Agents Cyclophosphamide Anti-Bacterial Agents Combined Modality Therapy Time Factors Patient Compliance Dose-Response Relationship, Drug Drug Combinations Anti-HIV Agents Administration, Oral Antineoplastic Agents Pyrazinamide Treatment Failure Vincristine HIV Infections Retrospective Studies Rifampin Isoniazid Doxorubicin Prospective Studies Fluorouracil Cisplatin Methotrexate Survival Analysis Recurrence Prednisone Tuberculosis, Multidrug-Resistant Clinical Trials as Topic Metronidazole Follow-Up Studies Double-Blind Method Disease-Free Survival Amoxicillin Ethambutol Etoposide Survival Rate Infusions, Intravenous Bismuth Immunosuppressive Agents Prognosis Clarithromycin Remission Induction Drug Substitution Antiretroviral Therapy, Highly Active Doxycycline Antibiotics, Antitubercular Antimalarials Diarylquinolines Medication Adherence Deoxycytidine Cytarabine Tuberculosis Paclitaxel Anti-Infective Agents Randomized Controlled Trials as Topic Benzoxazines Artemisinins Salvage Therapy Ritonavir Viral Load Antiviral Agents Antibodies, Monoclonal Anti-Ulcer Agents Drug Resistance, Viral Neoplasm Staging Reverse Transcriptase Inhibitors HIV Protease Inhibitors Directly Observed Therapy Helicobacter pylori Area Under Curve Antineoplastic Agents, Alkylating Ofloxacin Penicillin G Benzathine Helicobacter Infections Vinblastine Microbial Sensitivity Tests Chemotherapy, Adjuvant HIV-1 Leucovorin Neoplasms Penicillins Tuberculosis, Pulmonary Omeprazole Tinidazole Leprostatic Agents Random Allocation Lung Neoplasms Lymphoma, Non-Hodgkin Azithromycin Pilot Projects Carboplatin Drug Costs Ifosfamide Taxoids CD4 Lymphocyte Count Neutropenia

No FAQ available that match "treatment regimens"